Sign in
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Journal article   Open access  Peer reviewed

Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes

Christopher R Cogle, Elizabeth Wise, Amy M Meacham, Claudia Zierold, Jay H Traverse, Timothy D Henry, Emerson C Perin, James T Willerson, Stephen G Ellis, Marjorie Carlson, …
Circulation research, Vol.115(10), pp.867-874
2014-10-24
PMCID: PMC4358751
PMID: 25136078

Abstract

Humans Middle Aged Myocardial Ischemia - blood Stroke Volume - physiology Male Treatment Outcome Ventricular Dysfunction, Left - diagnosis Biomarkers - blood Bone Marrow - physiology Antigens, CD34 - blood Colony-Forming Units Assay - methods CD11b Antigen - blood Ventricular Dysfunction, Left - blood Female Aged Myocardial Ischemia - diagnosis Bone Marrow Cells - metabolism
url
https://doi.org/10.1161/CIRCRESAHA.115.304353View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.102 Stem Cell Research
1.102.110 Mesenchymal Stem Cells
Web Of Science research areas
Cardiac & Cardiovascular Systems
Hematology
Peripheral Vascular Disease
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details